medigraphic.com
ISSN 0016-3813 (Print)

2003, Number 3

<< Back Next >>

Gac Med Mex 2003; 139 (3)

Physiopatology ofVascular Complications of Diabetic Foot.

Arana-Conejo V, Méndez-F JD

Language: Spanish
References: 74
Page: 255-264
PDF size: 86.37 Kb.


ABSTRACT

Objective: To review the literature on vascular complications of diabetic foot with special interest in ulcerative lesions and their prevention and treatment. Materials: Representative papers were selected through a computer MEDLINE search from 1980 to 2001. Results: In diabetes mellitus, physiologic and biochemical mechanisms that regulate coordinated behavior between blood circulation and vessel wall are damaged, both in small and large vessels. Vascular alterations observed in patients with diabetes result in peripheral vascular disease with special characteristics in these patients that produce a greater tendency in diabetic than non-diabetic patients for chronic ulcerative lesions of foot and lesser capacity for healing. These lesions frequently result in amputation of the lower limb. Nevertheless efforts made for preventing and healing ulcerative complications, results are unsatisfactory. Conclusions: It is necessary to research new methods for preventing and healing vascular complications of diabetic foot with special attention to improving damaged physiologic and biochemical mechanisms in diabetes mellitus.


REFERENCES

  1. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183-1197.

  2. Brownlee M, Cerami A. The biochemistry of the complications of diabetes mellitus. Annu Rev Biochem 1981;50:385-432.

  3. Méndez JD, Balderas FG, Corona de la Peña N, Morales ME, Palomar MM, De Haro HR. La investigación en diabetes mellitus y aterosclerosis. Efecto de la L-arginina y las poliaminas. En: Aguirre GH (ed): Actualidades Médico-Quirúrgicas Vol II. Editorial Prado, S.A. de C.V. México, D.F. 2000 pp 277-298. ISBN –968-6899-34-0.

  4. Levin ME. Preventing amputation in the patient with diabetes. Diabetes Care 1995;18(10):1383-1394.

  5. Ollendorf, DA, Kotsanos J, James G, Wishner WJ, Friedman M, Cooper, T, Bittoni, M, Oster G. Potential economic benefits of lower-extremity amputation prevention strategies in diabetes. Diabetes Care 1998;21(8):1240-1245.

  6. Potter PJ. Watch your step! Can Med Ass J 1998;159(3) :218-219.

  7. Mayfield JA, Reiber GE, Sanders LJ, Janisse D, Pogach LM. Preventive foot care in people with diabetes. Diabetes Care 1998; 21(12):2161-2177.

  8. American Diabetes Association. Preventive foot care in people with diabetes. Diabetes Care 1998;21(12): 2178-2179.

  9. Hill SL, Holtzman GI, Buse R. The effects of peripheral vascular disease with osteomyelitis in the diabetic foot. Am J Surg 1999;177 (4):282-286.

  10. Pittet D, Wyssa B, Herter-Clavel C, Kursteiner K, Vaucher J, Lew PD. Outcome of diabetic foot infections treated conservatively: a retrospective cohort study with long-term follow up. Arch Intern Med 1999;159(8):851-856.

  11. Armstrong DG, Stacpoole-Shea SB, Nguyen H, Harkless LB. Lengthening of the Achiles tendon in diabetic patients who are at high risk for ulceration of the foot. J Bone Joint Surg Am 1999;81-A(4):535-538.

  12. Van Gils CC, Wheeler LA, Mellstrom M, Brinton EA, Mason S, Wheeler CG. Amputation prevention by vascular surgery and podiatry collaboration in high-risk diabetic and nondiabetic patients: the operation desert foot experience. Diabetes Care 1999;22(5):678-683.

  13. Ahroni JH, Boyko EJ, Forsberg RC. Clinical correlates of plantar pressure among diabetic veterans. Diabetes Care 1999;22(6):965-972.

  14. Bloomgarden ZT. The European Association for the Study of Diabetes Annual Meeting, 1998: Complications of diabetes. Diabetes Care 1999;22(8):1364-1370.

  15. Dargis V, Olga P, Jonushaite A, Vileikyte L, Boulton AJ. Benefits of a multidisciplinary approach in the management of recurrent diabetic foot ulceration in Lithuania: A prospective study. Diabetes Care 1999;22(9):1428-1431.

  16. Pinzur MS. American Orthopedic Foot and Ankle Society Diabetic Shoe Survey. Diabetes Care 1999;22(12)2099-2100.

  17. Colwell JA. Peripheral vascular disease in diabetes mellitus. In: Clinical Diabetes Mellitus. A Problem-oriented Approach. John KD (Edit) Thieme, Third Edition, 2000,Chapter 30, pp 561-570.

  18. Coleman WC. The diabetic foot. In: Clinical Diabetes Mellitus. A Problem-oriented Approach. John KD (Edit) Thieme, Third Edition, 2000, Chapter 31, pp 571-580.

  19. Levin ME. Pathophysiology of diabetic foot lesions In: Clinical Diabetes Mellitus. A Problem-oriented Approach. John KD (Edit) Thieme, Third Edition, 2000, Chapter 31, pp 581-598.

  20. Hobgood E. Conservative therapy of foot abnormalities, infections, and vascular insufficiency. In: Clinical Diabetes Mellitus. A Problem-oriented Approach. John KD (Edit) Thieme, Third Edition, 2000, Chapter 31, pp 599-609.

  21. Bloomgarden ZT. American Diabetes Association 60th Scientific Sessions, 2000: The diabetic foot. Diabetes Care 2001;24(5):946-951.

  22. Metha SS, Suzuki S, Glick HA, Schulman KA. Determining an episode of care using claims data: diabetic foot ulcer. Diabetes Care 1999;22(7):1110-1115.

  23. Reiber GE, Bokyo EJ, Smith DG. Lower extremity foot ulcers and amputations in diabetes. In Harris M.I., Cowie C.C., Stem, M.P., et al (eds): Diabetes in America, ed. (DHHS Publication No. 95-1468). Washington, DC, US Government Printing Office, 1995,pp 409-428.

  24. Bloomgarden ZT. European Association for the Study of Diabetes Annual Meeting, 1999: Complications of diabetes. Diabetes Care 2000;23(4):1423-1428.

  25. Brem H, Balledux J, Bloom T, Kerstein M, Hollier L. Healing of diabetic foot ulcers and pressure ulcers with human skin equivalent: A new paradigm in wound healing. Arch Surg 2000;135(6):627-634.

  26. Matsuda T, Morishita E, Jokaji H, Asakura H, Saito M, Yoshida T, Takemoto K. Mechanism on disorders of coagulation and fibrinolysis in diabetes. Diabetes 1996;45(3S):109S-110S.

  27. Donnelly R, Emslie-Smith A, Alistaer M, Gardner I, Morris AD. Vascular complications of diabetes. Br Med J 2000;320(7241):1062-1066.

  28. Sobening IA, Tertov VV, Orekhov AN. Atherogenic modified LDL in diabetes. Diabetes 1996;45(3S):35S-39S.

  29. Bloomgarden ZT. The 32nd Annual Meeting of the European Association for the Study of Diabetes: Macrovascular disease. Diabetes Care 1997;20(7):1198-1201.

  30. Bloomgarden ZT. American European Association Annual Meeting, 1997: Endothelial dysfunction, neuropathy and the diabetic foot, diabetic mastopathy, and erectile dysfunction. Diabetes Care 1998;21(1):183-189.

  31. Devaraj S. Low-density lipoprotein postsecretory modification, monocyte function, and circulating adhesion molecules in type 2 diabetic patients with and whithout macrovascular complications: The effect of tocopherol supplementation. Circulation 2000;102(2):191-196.

  32. Suzuki LA, Poot M, Gerrity RG, Bornfeldt KE. Diabetes accelerates smooth muscle accumulation in lesions of atherosclerosis: Lack of direct growth-promoting effects of high glucose levels. Diabetes 2001;50(4):851-860.

  33. Méndez JD. Productos finales de glicacion avanzada y complicaciones cronicas de la diabetes mellitus. Gaceta Médica de México. 2003;139(1):49-55.

  34. Sekiguchi N, Sano T, Ono Y, Hashimoto T, Kuroki T, Iwashinge K, Sako Y, Nawata H Umeda F. Reduced prostacyclin-stimulating factor expression by vascular smooth muscle cells in diabetes. Diabetes 1996;45(2S):126A.

  35. Mazzanti L, Rabini RA, Fumelli P, Martarelli D, Staffolani R, Salvolini E, Curatola G. Altered platelet membrane dynamic properties in type I diabetes. Diabetes 1997;46 (12):2069-2074.

  36. Lehto S, Niskanen L, Suhonen M, Ronnemaa T, Laakso M. Medial artery calcification: A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Biol 1996;16(8):978-983.

  37. Laughlin RT, Calhoun JH, Mader JT. The diabetic foot. Am Acad Orthop Surg 1995;3:218-225.

  38. Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation: Basis for prevention. Diabetes Care 1990;13:513-521.

  39. McNeely MJ, Bokyo EJ, Ahroni JH. The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration: How great are the risks? Diabetes Care 1995;18:216-219.

  40. Brodsky JW. Outpatient diagnosis and care of the diabetic foot. In Heckman J.D. (ed): Instructional Course Lectures. Park Ridge, III., American Academy of Orthopaedic Surgeons, 1993, pp 121-131.

  41. Irwin ST, Gilmore J, McGrann S. Blood flow in diabetics with lessions due to small vessel disease. Br J Surg 1988;75:1201-1206.

  42. LoGerfo FW, Coffman JD. Current concepts: Vascular and microvascular disease of the foot in diabetes: Implications for foot care. N Engl J Med 1984;311:1615-1619.

  43. Brodsky J. The diabetic foot. In Mann R.A., Coughlin M.J. (eds): Surgery of the foot and Ankle, 6th ed. St. Louis, Mosby-Year Book, 1993, pp 877-958.

  44. Young MJ, Cavanagh PR, Thomas G. The affect of callus removal on dynamic plantar foot pressures in diabetic patients. Diabet Med 1992;9:55-57.

  45. Veves A, Murray HJ, Young MJ. The risk of foot ulceration in diabetic patients with high foot pressure: A prospective study. Diabetologia 1992;35:660-663.

  46. Wagner FW Jr. A classification and treatment program for diabetic, neuropathic, and dysvascular foot problems. In Instruccional Course Lectures. St. Louis, CV Mosby, American Academy of Orthopaedic Surgeons, 1979, pp 143-165.

  47. Risau W. Mechanism of angiogenesis. Nature 1997:386: 671-674.

  48. Folkman J, D´Amore PA. Blood vessel formation: What is its molecular basis. Cell 1996;87:1153.

  49. Cotran RS, Kumar V, Collins T. Reparación de los tejidos: proliferación celular, fibrosis y curación de las heridas. En: Robbins Patología estructural y funcional, capítulo 4, sexta edición, McGraw-Hill Interamericana, México, 2000, pp 110-120.

  50. Hanahan D. Signaling vascular morphogenesis and maintenance. Science 1997;277:48.

  51. Davis S. Isolation of angiopoietin-1, a ligand for the TIE2 receptor by secretion-trap expression cloning. Cell 1996;87:1161.

  52. Maisonpierre PC. Angiopoietin-2, a natural antagonist for TIE2 that disrupts in vivo angiogenesis. Science 1997;277:55.

  53. Dvorak HF. Vascular permeability factor/vascular endothelial growth factor, microvascular hypermeability, and angiogenesis. Am J Pathol 1995;146:1029.

  54. Brooks PC. Requirement of vascular integrin anb3 for angiogenesis. Science 1994;264:569.

  55. Bornstein P. Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1. J Cell Biol 1995;130:503.

  56. Sage EH. Pieces of eight: bioactive fragments of extracellular proteins as regulators of angiogenesis. Trends Cell Biol 1997;7:182.

  57. Rivard A, Silver M, Fabre JE, Magner M, Kearney M, Isner JM. Diabetes impairs angiogenesis in limb ischemia. Circulation 1997;96(8S):175-L.

  58. Shaper W, Buschmann I. Collateral circulation and diabetes. Circulation 1999;99(17)2224-2226.

  59. Waltenberg J, Lange J, Kranz A. Vascular endothelial growth factor a induced chemotaxis of monocytes is attenuated in patients with diabetes mellitus: a potential predictor for the individual capacity to develop collaterals. Circulation 2000;102 (2):185-190.

  60. Schatteman GC, Hanlon HD, Jiao C, Dodds SG, Christy BA. Blood-devired angioblasts accelerate blood-flow restoration in diabetic mice. J Clin Invest 2000;106(4):571-578.

  61. Sánchez CJE, Islas AS. Pie del diabético. En: Islas AS, Lifshitz, GA (eds): Diabetes mellitus, 2a. Ed. McGraw-Hill Interamericana 2000 pp 277-293.

  62. Faglia E, Favales F, Aldeghi A, Calia P, Quarantiello A, Oriani G, Michael M, Campagnoli P, Morabito A. Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer: A randomized study. Diabetes Care 1996;19(12):1338-1343

  63. Cianci P. Consensus development conference on diabetic foot wound care: A randomized controlled trial does support use of adjunctive hyperbaric oxygen therapy. Diabetes Care 2000;23(6):873

  64. Muncuoglu KY, Ingber A, Gilead L, Stessman J, Friedmann R, Schulman H, Bichucher H, Ioffe-Uspensky I, Miller J, Galun R, Raz I. Maggot therapy for the treatment of diabetic foot ulcer. Diabetes Care 1998;21(11):2030-2031-65. Schindl A, Schindl M, Schon H, Knobler R, Havelec L, Schindl L. Low-intensity laser irradiation improves skin circulation in patients with diabetic microangiopathy. Diabetes Care 1998;21(4):580-584.

  65. Van Schie C, Whalley A, Vileikyte L, Wignall T, Hollis S, Boulton A. Efficacy of injected liquid silicone in the diabetic foot to reduce risk factors for ulceration: a randomized double-blind placebo-controlled trial. Diabetes Care 2000;23(5):634-638.

  66. Salam AA. The role of vascular surgery in the management of arterial insufficiency in diabetes. In: Davidson JK (ed): Clinicla Diabetes Mellitus. A Problem-Orientes Approach, 3rd ed. Thieme 2000. pp. 611-620.

  67. Corona de la Peña N, Sosa-Melgarejo JA, Méndez JD. Aterosclerosis experimental. Cambios bioquímicos y vasculares. Rev Med IMSS, 1999;37(5):337-338.

  68. Méndez JD, Zarzoza E. Inhibition of platelet aggregation by L-arginine and polyamines in alloxan treated rats. Biochem Mol Biol Int, 1997;43:311-318.

  69. Méndez JD, Balderas F. Regulation of hyperglucemia and dyslipidemia by exogenous L-arginine in diabetic rats. Biochimie 2001 May; 83(5):453-458.

  70. Méndez JD, Arreola MA. Effect of L-arginine on pancreatic arginase activity and polyamines in alloxan treated rats. Biochem Int, 1992;28:569-575.

  71. Méndez JD. Poliaminas. En: Bioquímica e Inmunología. Vol. II Hicks JJ y Díaz Zagoya CC (Eds) Facultad de Medicina, Universidad Nacional Autónoma de México; 1989 pp 365-85.

  72. Ketteler M, Border WA, Noble NA. Cytokines and L-arginine in renal injury and repair. Am J Physiol 1994;267(36):F197-F207.

  73. Méndez JD. Polyamines and human reproduction. In: The Physiology of Polyamines. Vol.1. Bachrach, U and Heimer Y (eds). C.R.C. Press, Inc., Florida, U.S.A. 1989 pp 23-36.

  74. Méndez JD, Ramos HG. Animal models in diabetes research. Arch Med Res, 1994;25:367-75.




2020     |     www.medigraphic.com